OCGN

OCGN

Biotech
warm
Last Tier
Market Cap
N/A
Float
N/A
Short Interest
N/A
Predictions
2
Hit Rate
N/A

Price Chart

Powered by TradingView

Technical Analysis

Company Profile

Upcoming Catalysts

PDUFA FDA PDUFA date for OCGN drug candidate
Feb 28, 2026
CONFERENCE Healthcare/Tech conference presentation by OCGN
Mar 01, 2026
EARNINGS Q4 earnings report for OCGN (EPS est: $-0.0592)
Mar 04, 2026

Prediction History

Date Score Tier Gap % Price D+3 D+5 Result
Feb 26, 2026 73 warm +65.6% $0.00
Feb 26, 2026 73 warm +32.2% $0.00

External Resources

← Back to Track Record